Financial Review: TRACON Pharmaceuticals (NASDAQ:TCON) & Tevogen Bio (NASDAQ:TVGN)
TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) and Tevogen Bio (NASDAQ:TVGN – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Insider & Institutional Ownership 11.6% of TRACON […]
More Stories
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...